9783725810499 - Systemic Autoinflammatory Diseases: Clinical Rheumatic Challenges Series 2 (16 risultati)

Condizione: New.

Hardback or Cased Book. Condizione: New. Systemic Autoinflammatory Diseases: Clinical Rheumatic Challenges Series 2. Book.

Condizione: As New. Unread book in perfect condition.

Condizione: New. In.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

HRD. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Hardcover. Condizione: new. Hardcover. Autoinflammation, as a relatively new field in clinical rheumatology, has gained increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows for a deeper understanding of the closely linked diseases, such as inflammasomopathies, interferonopathies, relopathies, and proteasome-associated syndromes. These insights have not only improved their classification, but have also helped us to identify new treatment targets of pro-inflammatory cytokines, including IL-1ss, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still an urgent medical need, especially in the recognition of syndromes of undifferentiated recurrent fever and reliable outcome measures, for the confirmation of data from controlled clinical trials, in addition to data from registers regarding patients' long-term experiences. This Special Issue welcomed all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasing linked to immunology. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

HRD. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Condizione: New. Print on Demand.

Condizione: New. Print on Demand.

Condizione: New. PRINT ON DEMAND.

Hardcover. Condizione: new. Hardcover. Autoinflammation, as a relatively new field in clinical rheumatology, has gained increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows for a deeper understanding of the closely linked diseases, such as inflammasomopathies, interferonopathies, relopathies, and proteasome-associated syndromes. These insights have not only improved their classification, but have also helped us to identify new treatment targets of pro-inflammatory cytokines, including IL-1ss, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still an urgent medical need, especially in the recognition of syndromes of undifferentiated recurrent fever and reliable outcome measures, for the confirmation of data from controlled clinical trials, in addition to data from registers regarding patients' long-term experiences. This Special Issue welcomed all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasing linked to immunology. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Hardcover. Condizione: new. Hardcover. Autoinflammation, as a relatively new field in clinical rheumatology, has gained increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows for a deeper understanding of the closely linked diseases, such as inflammasomopathies, interferonopathies, relopathies, and proteasome-associated syndromes. These insights have not only improved their classification, but have also helped us to identify new treatment targets of pro-inflammatory cytokines, including IL-1ss, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still an urgent medical need, especially in the recognition of syndromes of undifferentiated recurrent fever and reliable outcome measures, for the confirmation of data from controlled clinical trials, in addition to data from registers regarding patients' long-term experiences. This Special Issue welcomed all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasing linked to immunology. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Autoinflammation, as a relatively new field in clinical rheumatology, has gained increasing importance in recent years. The number of identified entities and affected patients has gradually increased, and some of the involved pathways have already been identified. This progress allows for a deeper understanding of the closely linked diseases, such as inflammasomopathies, interferonopathies, relopathies, and proteasome-associated syndromes. These insights have not only improved their classification, but have also helped us to identify new treatment targets of pro-inflammatory cytokines, including IL-1ß, IL-6, interferon-, and TNF-alpha. Nevertheless, there is still an urgent medical need, especially in the recognition of syndromes of undifferentiated recurrent fever and reliable outcome measures, for the confirmation of data from controlled clinical trials, in addition to data from registers regarding patients' long-term experiences. This Special Issue welcomed all types of papers on the broad spectrum of clinical characteristics, prognosis, pathophysiology, and treatment of autoinflammatory diseases. The goal of this Special Issue is to further raise awareness of autoinflammatory processes and to better separate them from well-established autoimmune diseases. It is clear that we have entered a new age in this complex field, as rheumatology is increasing linked to immunology.

Buch. Condizione: Neu. Systemic Autoinflammatory Diseases | Clinical Rheumatic Challenges Series 2 | Buch | Englisch | 2024 | MDPI AG | EAN 9783725810499 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.